Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
biochemistry, genetics and molecular biology
Clinicopathological significance of KU70/KU80, a key DNA damage repair protein in breast cancer
Breast Cancer Research and Treatment, Volume 139, No. 2, Year 2013
Notification
URL copied to clipboard!
Description
Although the role of BRCA1 and the homologous recombination (HR) pathway in breast cancer (BC) has been extensively studied, the alternative repair pathway for DNA double-strand breaks (DSBs), non-homologous end-joining (NHEJ) remains to be defined. Ku proteins bind to DNA DSB ends and play a key role in NHEJ. In this study we aimed to assess the expression and biological significance of the KU70/KU80 heterodimer in the different molecular classes of BC. The expression of KU70/KU80 was assessed immunohistochemically in a well-characterised and annotated series of 1302 unselected invasive BC cases with a long-term follow-up together with 25 cases with known BRCA1 mutations. The results were correlated with clinicopathological parameters, other DNA repair proteins and patient outcome. The expression of KU70/KU80 protein was further evaluated in various BC cell lines using western blotting and reverse-phase protein microarray (RPPA). Nuclear KU70/KU80 expression was correlated with features of poor prognosis including higher histological grade, lymphovascular invasion, negative oestrogen receptor expression, basal-like phenotype, P53 and CHK1 positivity. KU70/KU80 was expressed in all BRCA1-associated tumours and showed an inverse correlation with nuclear BRCA1 protein and aberrant cytoplasmic RAD51 expression. RPPA confirmed these results and showed higher expression of KU70/KU80 in BRCA1-deficient cell line compared to BRCA1-proficient cell line. KU70/KU80 expression showed an association with disease-free interval; however, it was not an independent predictor of outcome. As a conclusion, KU70/KU80 may play a role in DNA DSBs repair in HR-deficient tumours. Further study of other NHEJ markers in sporadic BC is warranted. © 2013 Springer Science+Business Media New York.
Authors & Co-Authors
Alshareeda, Alaa Tarig
United Kingdom, Nottingham
University of Nottingham
Saudi Arabia, Riyadh
Ministry of Higher Education
Negm, Ola H.
United Kingdom, Nottingham
University of Nottingham
Egypt, Mansoura
Faculty of Medicine
Albarakati, Nada
United Kingdom, Nottingham
University of Nottingham
Green, Andew R.
United Kingdom, Nottingham
University of Nottingham
Nolan, Christopher C.
United Kingdom, Nottingham
University of Nottingham
Sultana, Rebeka
United Kingdom, Nottingham
University of Nottingham
Madhusudan, Srinivasan
United Kingdom, Nottingham
University of Nottingham
Benhasouna, Ahmed A.
United Kingdom, Nottingham
University of Nottingham
Tighe, Patrick J.
United Kingdom, Nottingham
University of Nottingham
Ellis, Ian O.
United Kingdom, Nottingham
University of Nottingham
Rakha, Emad A.
United Kingdom, Nottingham
University of Nottingham
Statistics
Citations: 63
Authors: 11
Affiliations: 3
Identifiers
Doi:
10.1007/s10549-013-2542-x
ISSN:
01676806
e-ISSN:
15737217
Research Areas
Cancer
Genetics And Genomics
Health System And Policy
Study Design
Cohort Study